Published in Gastroenterology on May 01, 2004
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology (2007) 3.39
Cancer in inflammatory bowel disease. World J Gastroenterol (2008) 2.12
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron (2010) 1.96
Three-dimensional endomicroscopy of the human colon using optical coherence tomography. Opt Express (2009) 1.87
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.63
Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis (2009) 1.53
Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol (2005) 1.51
Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc (2015) 1.40
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis (2011) 1.33
Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol (2008) 1.30
Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol (2009) 1.24
Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 1.21
Colitis and cancer: a tale of inflammatory cells and their cytokines. J Clin Invest (2008) 1.21
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis (2009) 1.10
Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol (2012) 1.09
The Role of Inflammation in the Pathogenesis of Colorectal Cancer. Curr Colorectal Cancer Rep (2009) 1.04
Murine models of colorectal cancer. Mamm Genome (2009) 1.03
Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Res (2009) 1.01
Emerging roles of the microbiome in cancer. Carcinogenesis (2013) 1.00
Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can J Gastroenterol (2009) 0.97
Molecular pathways: gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention. Clin Cancer Res (2013) 0.97
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
Surgery for inflammatory bowel disease. World J Gastroenterol (2008) 0.95
Colorectal cancer in inflammatory bowel disease. Gut Liver (2008) 0.94
Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol (2014) 0.92
Multi-target stool DNA test: a new high bar for noninvasive screening. Dig Dis Sci (2014) 0.91
Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates. Am J Gastroenterol (2009) 0.91
Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol (2006) 0.90
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther (2014) 0.89
Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis (2006) 0.88
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (review). Int J Oncol (2014) 0.86
Precancerous lesions in colorectal cancer. Gastroenterol Res Pract (2013) 0.86
p53 codon 72 polymorphism in patients affected with ulcerative colitis. J Gastroenterol (2007) 0.85
The approach to dysplasia surveillance in inflammatory bowel disease. Can J Gastroenterol (2006) 0.83
Gastrointestinal stem cells in health and disease: from flies to humans. Dis Model Mech (2016) 0.82
Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol (2007) 0.82
Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer. Anticancer Res (2010) 0.82
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointest Endosc Clin N Am (2014) 0.82
A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease. Tech Coloproctol (2015) 0.81
Interpersonal influences on patients' surgical decision making: the role of close others. J Behav Med (2011) 0.81
Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy. Can J Gastroenterol Hepatol (2014) 0.79
Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study. Dig Dis Sci (2011) 0.79
The microbiome and its potential as a cancer preventive intervention. Semin Oncol (2015) 0.79
Chromoendoscopy and Advanced Imaging Technologies for Surveillance of Patients with IBD. Gastroenterol Hepatol (N Y) (2012) 0.79
Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease. World J Gastroenterol (2013) 0.79
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol Nutr Food Res (2016) 0.79
Endoscopic Optical Coherence Tomography for Clinical Gastroenterology. Diagnostics (Basel) (2014) 0.78
Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation. Stem Cells Int (2015) 0.78
Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study. Cell Oncol (Dordr) (2011) 0.78
DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance. Inflamm Bowel Dis (2016) 0.78
Colorectal Cancer Screening in Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.78
Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study. Endosc Int Open (2016) 0.77
Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines. Cancer Lett (2013) 0.77
Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case. World J Surg Oncol (2015) 0.77
Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain. World J Gastroenterol (2013) 0.77
Colorectal neoplasia in IBD--a single-center analysis of patients undergoing proctocolectomy. Int J Colorectal Dis (2015) 0.76
Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer. Gastrointest Cancer Res (2009) 0.76
Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view. Therap Adv Gastroenterol (2013) 0.76
Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer. Cancer Lett (2012) 0.76
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol (2014) 0.76
Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance. Gastrointest Tumors (2014) 0.76
Effect of adenovirus-mediated PTEN gene on ulcerative colitis-associated colorectal cancer. Int J Colorectal Dis (2013) 0.76
The laminin response in inflammatory bowel disease: protection or malignancy? PLoS One (2014) 0.76
A thirty-year follow-up surveillance study for neoplasia of a dutch ulcerative colitis cohort. ScientificWorldJournal (2013) 0.76
Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol (2015) 0.75
Circulating DNA and its methylation level in inflammatory bowel disease and related colon cancer. Int J Clin Exp Pathol (2015) 0.75
Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry. Diagn Pathol (2014) 0.75
Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc(+/Min-FCCC) mice. World J Gastrointest Pharmacol Ther (2017) 0.75
Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped? Saudi J Gastroenterol (2014) 0.75
Republished: tracing PAKs from GI inflammation to cancer. Postgrad Med J (2014) 0.75
Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus). World J Gastroenterol (2016) 0.75
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report. World J Surg Oncol (2013) 0.75
Pseudopolyps in inflammatory bowel diseases: Have we learned enough? World J Gastroenterol (2017) 0.75
Inflammatory bowel disease associated neoplasia: A surgeon's perspective. World J Gastroenterol (2016) 0.75
Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2). Neoplasia (2017) 0.75
Perspectives on endoscopic surveillance of dysplasia in inflammatory bowel disease: a survey of academic gastroenterologists. Endosc Int Open (2017) 0.75
[Polypoid dysplasia in inflammatory bowel disease: differential diagnosis and further diagnostic and therapeutic approaches]. Pathologe (2011) 0.75
Inflammatory bowel disease: the problems of dysplasia and surveillance. Tech Coloproctol (2007) 0.75
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology (2003) 4.64
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology (2007) 3.39
Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2010) 2.62
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell (2013) 1.86
Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One (2012) 1.82
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol (2005) 1.79
Evaluation of quantitative image analysis criteria for the high-resolution microendoscopic detection of neoplasia in Barrett's esophagus. J Biomed Opt (2010) 1.76
Appendiceal mucinous cystadenoma is a neoplastic complication of IBD: case-control study of primary appendiceal neoplasms. Inflamm Bowel Dis (2009) 1.69
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology (2004) 1.59
Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol (2008) 1.57
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest (2010) 1.50
Diagnosis of colitis: making the initial diagnosis. Clin Gastroenterol Hepatol (2007) 1.48
Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis (2004) 1.42
Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol (2007) 1.42
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis (2011) 1.33
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis (2010) 1.28
Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci (2010) 1.25
Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology (2007) 1.23
Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis (2011) 1.21
Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology (2002) 1.21
Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc (2002) 1.19
Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res (2002) 1.15
Calcifying fibrous tumor of small intestine. Ann Diagn Pathol (2007) 1.14
Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res (2002) 1.13
Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol (2008) 1.07
Mesenteric paraganglioma: a case report and review of the literature. Arch Pathol Lab Med (2002) 1.01
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol (2010) 1.01
Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00
MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. Dis Colon Rectum (2007) 0.97
Clinical and prognostic features of rectal neuroendocrine tumors. Neuroendocrinology (2013) 0.96
Small bowel adenocarcinoma in Crohn's disease. J Gastrointest Surg (2011) 0.96
Goblet cell carcinoids at extraappendiceal locations of gastrointestinal tract: an underrecognized diagnostic pitfall. J Surg Oncol (2011) 0.95
Microcarcinoids in large intestinal adenomas. Am J Surg Pathol (2006) 0.95
Adenocarcinoma following ileal pouch-anal anastomosis for ulcerative colitis: review of 26 cases. Inflamm Bowel Dis (2009) 0.94
Colorectal carcinoma in indeterminate colitis. Inflamm Bowel Dis (2009) 0.94
A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans. Gastroenterology (2012) 0.92
Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology (2005) 0.91
Vital-dye enhanced fluorescence imaging of GI mucosa: metaplasia, neoplasia, inflammation. Gastrointest Endosc (2012) 0.90
Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel?: a prospective, randomized study involving 630 biopsies. J Clin Gastroenterol (2011) 0.87
Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease. Am J Surg Pathol (2006) 0.87
Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Inflamm Bowel Dis (2011) 0.85
A primary approach to cancers of unknown primary. J Natl Cancer Inst (2013) 0.85
WEO Newsletter. Dig Endosc (2015) 0.85
gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin. J Histochem Cytochem (2012) 0.84
Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis (2013) 0.84
Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors. J Clin Oncol (2013) 0.84
Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance. Inflamm Bowel Dis (2011) 0.83
Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors. Pancreas (2011) 0.82
Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett's esophagus surveillance population. Dig Dis Sci (2010) 0.82
Interpersonal influences on patients' surgical decision making: the role of close others. J Behav Med (2011) 0.81
Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia. BMC Cancer (2003) 0.81
Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest Endosc (2011) 0.81
Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology (2015) 0.79
Posttransplant CD30+ (Ki-1) anaplastic large cell lymphoma: a case report and review of the literature. Arch Pathol Lab Med (2003) 0.78
Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience. Dig Dis Sci (2014) 0.77
Segmentation of microscopic images of small intestinal glands with directional 2-D filters. Anal Quant Cytol Histol (2005) 0.77
Corpora amylacea in gastrointestinal leiomyomas: a clinical, light microscopic, ultrastructural and immunohistochemical study with comparison to hyaline globules. J Clin Pathol (2013) 0.76
High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn's colitis. Inflamm Bowel Dis (2013) 0.76
Intramuscular corpora amylacea adjacent to ileal low-grade neuroendocrine tumours (typical carcinoids): a light microscopic, immunohistochemical and ultrastructural study. J Clin Pathol (2013) 0.76
Intraepithelial lymphocytosis in architecturally normal small intestinal mucosa: association with morbid obesity. Arch Pathol Lab Med (2007) 0.75
Gastrointestinal autonomic nerve tumor in the colon. Am J Surg Pathol (2002) 0.75
Mucin-containing Rokitansky-Aschoff sinuses with extracellular mucin deposits. Am J Surg Pathol (2011) 0.75
Neurogenic polyps of the gastrointestinal tract: a clinicopathologic review with emphasis on differential diagnosis and syndromic associations. Arch Pathol Lab Med (2015) 0.75
Bleeding diathesis in amyloidosis with renal insufficiency associated with Crohn's disease: response to desmopressin. Am J Gastroenterol (2002) 0.75
Esophageal pathology: a brief guide and atlas. Otolaryngol Clin North Am (2013) 0.75
Esophagitis Dissecans Superficialis in a 49- year-old woman. Dig Endosc (2016) 0.75
Composite glandular-endocrine tumor of the stomach in atrophic gastritis. Am Surg (2010) 0.75